objective:conventional pharmacological and interventional approaches are often ineffective. We present a novel case report illustrating the potential use of omega-3 fatty acid supplementation in such patients.
Both conventional anti-arrhythmic drugs and anti-tachycardia pacing often provide only partial control. Radiofrequency ablation, the mainstay of treatment is technically challenging in children, and associated with significant procedural risks.
We present the potential use of omega-3 fatty acid supplementation in such patients.
method:A 5-year-old child presented with hypotensive sustained ventricular tachycardia
sinus rhythm was restored by DC cardioversion. Echocardiography revealed Dilated cardiomyopathy . intravenous and then oral amiodarone were administered . the maintenance dose of oral amiodarone was increased to maximum dose, He continued to experience frequent episodes of monomorphic sustained ventricular tachycardia
Mexilitine was added , but had little effect on the frequency of ongoing ventricular tachycardia. Radiofrequency ablation was not available for this age, then
he was commenced on treatment with omega-3 fatty acid supplementation (seven seas, pure cod liver oil 0.5 cc/kg/day )). Results:At further review 4 weeks later, he felt well and, dramatically
Prior to the initiation of omega-3 fatty acid supplementation, he had been experiencing 8-10 documented episodes of sustained ventricular tachycardia per day
conclusion:He has remained well for the past 4 months, since the introduction of omega-3 fatty acid supplementation, and there have been no further episodes of sustained ventricular tachycardia, such that radiofrequency ablation has not been required to date.